Shattuck Labs, Inc. Common Stock

Go to Shattuck Labs, Inc. Common Stock Website

$0.92

-0.07 (-7.07%)
Live
Previous Close

$0.99

Day Range

$0 - $0

Previous Day Range

$0.9133 - $1.15

Market Cap

$35.6 million USD

Day Vol.

0

Previous Day Vol.

94.2 million

Currency

USD

Primary Exchange

Nasdaq

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Shattuck Labs, a biotechnology company, announced that its CEO will present at the 24th Annual Needham Virtual Healthcare Conference on April 9, 2025. The company's lead program, SL-325, is a potential first-in-class DR3 antagonist antibody designed to treat inflammatory and immune-mediated diseases.

Related tickers: STTK.

Read Full Article

Shattuck Labs, a biotechnology company, announced that its CEO will present a corporate update and participate in one-on-one meetings at the upcoming J.P. Morgan Healthcare Conference.

Related tickers: STTK.

Read Full Article
Trending Tickers

Please sign in to view